Ignite Creation Date:
2024-05-05 @ 9:56 PM
Last Modification Date:
2024-10-26 @ 10:11 AM
Study NCT ID:
NCT00994136
Status:
COMPLETED
Last Update Posted:
2011-06-09
First Post:
2009-10-13
Brief Title:
Safety of Catheter Lock With or Without Heparin in Implanted Central Venous Catheters
Sponsor:
Universitaire Ziekenhuizen KU Leuven
Organization:
Universitaire Ziekenhuizen KU Leuven
Study Overview
Official Title:
Locking of Totally Implanted Venous Access Devices and Tunneled Catheters With or Without Heparin a Randomised Open-labeled Controlled Trial
Status:
COMPLETED
Status Verified Date:
2011-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Long-term central venous access devices are considered as safe for the administration of medication as chemotherapy but are also used for blood sampling For years these catheters have been locked with a heparin solution in order to avoid occlusion However no scientific evidence supports heparin locking when the device is not in use Advanced technology as needleless caps and valved catheters and port reservoirs confirms this trend to use saline only for locking these devices Therefore the investigators hypothesize is that there will be no difference in proportion of occlusions and catheter related bacteremia in long-term venous access devices locked with saline only versus with heparin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None